Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Protease inhibitors in the clinic.

Abbenante G, Fairlie DP.

Med Chem. 2005 Jan;1(1):71-104. Review.

PMID:
16789888
2.

Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors.

Parikh S, Gut J, Istvan E, Goldberg DE, Havlir DV, Rosenthal PJ.

Antimicrob Agents Chemother. 2005 Jul;49(7):2983-5.

4.

Aspartic proteases of Plasmodium falciparum as the target of HIV-1 protease inhibitors.

Savarino A, Cauda R, Cassone A.

J Infect Dis. 2005 Apr 15;191(8):1381-2; author reply 1382-3. No abstract available.

PMID:
15776390
5.

Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects.

Boffito M, Back D, Stainsby-Tron M, Hill A, Di Perri G, Moyle G, Nelson M, Tomkins J, Gazzard B, Pozniak A.

Br J Clin Pharmacol. 2005 Jan;59(1):38-42.

6.

Antiretrovirals as antimalarial agents.

Skinner-Adams TS, McCarthy JS, Gardiner DL, Hilton PM, Andrews KT.

J Infect Dis. 2004 Dec 1;190(11):1998-2000. Epub 2004 Nov 3.

PMID:
15529265
7.

The role of Plasmodium falciparum food vacuole plasmepsins.

Liu J, Gluzman IY, Drew ME, Goldberg DE.

J Biol Chem. 2005 Jan 14;280(2):1432-7. Epub 2004 Oct 28.

8.

Genomics and malaria control.

Vernick KD, Waters AP.

N Engl J Med. 2004 Oct 28;351(18):1901-4. Review. No abstract available.

PMID:
15509825
9.

Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy.

Omara-Opyene AL, Moura PA, Sulsona CR, Bonilla JA, Yowell CA, Fujioka H, Fidock DA, Dame JB.

J Biol Chem. 2004 Dec 24;279(52):54088-96. Epub 2004 Oct 18.

10.

Atazanavir: a new protease inhibitor to treat HIV infection.

Musial BL, Chojnacki JK, Coleman CI.

Am J Health Syst Pharm. 2004 Jul 1;61(13):1365-74. Review. Erratum in: Am J Health Syst Pharm. 2004 Nov 1;61(21):2243.

PMID:
15287232
11.

Antimalarial drug discovery: efficacy models for compound screening.

Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S.

Nat Rev Drug Discov. 2004 Jun;3(6):509-20. Review. No abstract available.

PMID:
15173840
12.

Antimalarial activities of novel synthetic cysteine protease inhibitors.

Lee BJ, Singh A, Chiang P, Kemp SJ, Goldman EA, Weinhouse MI, Vlasuk GP, Rosenthal PJ.

Antimicrob Agents Chemother. 2003 Dec;47(12):3810-4.

13.

Aspartic proteases from Plasmodium chabaudi: a rodent model for human malaria.

Martins TM, Novo C, do Rosário VE, Domingos A.

Acta Trop. 2003 Dec;89(1):1-12. Review.

PMID:
14636976
14.

Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man.

Dame JB, Yowell CA, Omara-Opyene L, Carlton JM, Cooper RA, Li T.

Mol Biochem Parasitol. 2003 Aug 11;130(1):1-12.

PMID:
14550891
15.
16.

Novel uncomplexed and complexed structures of plasmepsin II, an aspartic protease from Plasmodium falciparum.

Asojo OA, Gulnik SV, Afonina E, Yu B, Ellman JA, Haque TS, Silva AM.

J Mol Biol. 2003 Mar 14;327(1):173-81.

PMID:
12614616
17.

Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients.

Hsu A, Isaacson J, Brun S, Bernstein B, Lam W, Bertz R, Foit C, Rynkiewicz K, Richards B, King M, Rode R, Kempf DJ, Granneman GR, Sun E.

Antimicrob Agents Chemother. 2003 Jan;47(1):350-9.

18.

Simultaneous determination of indinavir, ritonavir and lopinavir (ABT 378) in human plasma by high-performance liquid chromatography.

Ray J, Pang E, Carey D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Aug 5;775(2):225-30.

PMID:
12113989
19.

Fate of haem iron in the malaria parasite Plasmodium falciparum.

Egan TJ, Combrinck JM, Egan J, Hearne GR, Marques HM, Ntenteni S, Sewell BT, Smith PJ, Taylor D, van Schalkwyk DA, Walden JC.

Biochem J. 2002 Jul 15;365(Pt 2):343-7.

Supplemental Content

Support Center